Government Travel Expenses
Original Data
$1,702.57
Vice President, Public Affairs and Marketing
May 11, 2024 to May 15, 2024
Destination:
New York City, New York, United States
Organization:
National Gallery of Canada
Reference No:
TR12699
Similar Data
$60.45
Vice President, Public Affairs and Marketing
Mar 20, 2024
Destination:
Montreal, Quebec, Canada
Organization:
National Gallery of Canada
Reference No:
TR12663
$8,080.01
Vice President, Public Affairs and Marketing
Apr 12, 2024 to Apr 22, 2024
Destination:
Venice, Italy, Europe
Organization:
National Gallery of Canada
Reference No:
TR12662
$703.17
Vice President, Public Affairs and Marketing
May 21, 2024 to May 23, 2024
Destination:
Stellarton, Nova Scotia, Canada
Organization:
National Gallery of Canada
Reference No:
TR12700
$1,238.99
Vice President, Public Affairs and Marketing
Mar 7, 2024 to Mar 11, 2024
Destination:
Halifax, Nova Scotia, Canada
Organization:
National Gallery of Canada
Reference No:
TR12635
$316.57
Vice President, Public Affairs and Marketing
May 27, 2023 to Mar 27, 2024
Destination:
Ottawa, Ontario, Canada
Organization:
National Gallery of Canada
Reference No:
APRIL 9, 2024_LL
$783.19
Vice President, Public Affairs and Marketing
Oct 14, 2023 to Oct 18, 2023
Destination:
Montréal, Québec, Canada
Organization:
National Gallery of Canada
Reference No:
TR12546
$378.63
Vice President, Public Affairs and Marketing
Aug 4, 2024 to Aug 8, 2024
Destination:
Halifax, Nova Scotia, Canada
Organization:
National Gallery of Canada
Reference No:
TR12770
$3,449.40
Director and CEO
May 14, 2024 to May 16, 2024
Destination:
New York, New York, United States
Organization:
National Gallery of Canada
Reference No:
TR12571
$5,138.63
Director and CEO
Jan 24, 2024 to Jan 31, 2024
Destination:
New York, New York, United States
Organization:
National Gallery of Canada
Reference No:
TR12568
$3,783.73
Vice President, Infectious Diseases and Vaccination Programs Branch
Sep 20, 2023 to Sep 23, 2023
Destination:
New York City, New York, United States
Organization:
Public Health Agency of Canada
Reference No:
T-2024-P7-00591